These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1690535)

  • 21. Human T- and B-cell epitopes of E1 glycoprotein of rubella virus.
    Chaye H; Ou D; Chong P; Gillam S
    J Clin Immunol; 1993 Mar; 13(2):93-100. PubMed ID: 8320313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein.
    Megret F; Hugnot JP; Falconar A; Gentry MK; Morens DM; Murray JM; Schlesinger JJ; Wright PJ; Young P; Van Regenmortel MH
    Virology; 1992 Apr; 187(2):480-91. PubMed ID: 1372140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SIV neutralization epitopes.
    Javaherian K; Langlois AJ; LaRosa GJ
    Chem Immunol; 1993; 56():78-90. PubMed ID: 7680868
    [No Abstract]   [Full Text] [Related]  

  • 24. Mapping T-cell epitopes of rubella virus structural proteins E1, E2, and C recognized by T-cell lines and clones derived from infected and immunized populations.
    Ou D; Chong P; Tingle AJ; Gillam S
    J Med Virol; 1993 Jul; 40(3):175-83. PubMed ID: 7689090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope mapping of envelope glycoprotein E1 of hog cholera virus strain Brescia.
    van Rijn PA; van Gennip HG; de Meijer EJ; Moormann RJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2053-60. PubMed ID: 7691986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serologically defined linear epitopes in the E2 envelope glycoprotein of Semliki Forest virus.
    Ariel N; Lehrer S; Elhanaty E; Sabo T; Brodt P; Lachmi B; Katz D; Levin R; Grosfeld H; Velan B
    Arch Virol; 1990; 113(1-2):99-106. PubMed ID: 1696808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides.
    Chassot S; Lambert V; Kay A; Godinot C; Roux B; Trepo C; Cova L
    Virology; 1993 Jan; 192(1):217-23. PubMed ID: 7685963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus.
    Gromowski GD; Barrett AD
    Virology; 2007 Sep; 366(2):349-60. PubMed ID: 17719070
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Humoral immune response to primary rubella virus infection.
    Wilson KM; Di Camillo C; Doughty L; Dax EM
    Clin Vaccine Immunol; 2006 Mar; 13(3):380-6. PubMed ID: 16522781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.
    Chaye HH; Mauracher CA; Tingle AJ; Gillam S
    J Clin Microbiol; 1992 Sep; 30(9):2323-9. PubMed ID: 1383269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of a neutralizing domain in isolates of rubella virus in Cordoba, Argentina.
    Cordoba P; Grutadauria SL; Cuffini C; Zapata MT
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):493-5. PubMed ID: 9220172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Definition of three minimal T helper cell epitopes of rubella virus E1 glycoprotein.
    Marttila J; Ilonen J; Lehtinen M; Parkkonen P; Salmi A
    Clin Exp Immunol; 1996 Jun; 104(3):394-7. PubMed ID: 9099921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration and mapping of highly carbohydrate-dependent epitopes in the herpes simplex virus type 1-specified glycoprotein C.
    Sjöblom I; Lundström M; Sjögren-Jansson E; Glorioso JC; Jeansson S; Olofsson S
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():545-54. PubMed ID: 2434609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of epitopes within the amino acid sequence of the Epstein-Barr virus major envelope glycoprotein, gp340, recognized by hyperimmune rabbit sera.
    Pither RJ; Nolan L; Tarlton J; Walford J; Morgan AJ
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1409-15. PubMed ID: 1376768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.
    Starkey WG; Newcombe J; Corbett KM; Liu KM; Sanders PG; Best JM
    J Clin Microbiol; 1995 Feb; 33(2):270-4. PubMed ID: 7714176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential antibody responses to rubella virus infection in males and females.
    Mitchell LA; Zhang T; Tingle AJ
    J Infect Dis; 1992 Dec; 166(6):1258-65. PubMed ID: 1431244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and characterization of rubella virus glycoprotein E1 in yeast cells.
    Wen H; Wang Z
    Intervirology; 2005; 48(5):321-8. PubMed ID: 15956800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a specific serological test and an efficient subunit vaccine to control bovine leukemia virus infection.
    Portetelle D; Burny A; Desmettre P; Mammerickx M; Paoletti E; Zavada J
    Dev Biol Stand; 1990; 72():81-90. PubMed ID: 1704325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lassa virus glycoproteins: antigenic and immunogenic properties of synthetic peptides to GP1.
    Krasko AG; Moshnikova AB; Kozhich AT; Tchikin LD; Ivanov VT; Vladyko AS; Lukashevich IS
    Arch Virol; 1990; 115(1-2):133-7. PubMed ID: 1701079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of serum antibody reactivities to a conformational and to linear antigenic sites in the external envelope glycoprotein of simian immunodeficiency virus (SIVmac) induced by infection and vaccination.
    McBride BW; Corthals G; Rud E; Kent K; Webster S; Cook N; Cranage MP
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1033-41. PubMed ID: 7685372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.